ES2190535T3 - Composiciones de lectina y uso de las mismas. - Google Patents

Composiciones de lectina y uso de las mismas.

Info

Publication number
ES2190535T3
ES2190535T3 ES97927282T ES97927282T ES2190535T3 ES 2190535 T3 ES2190535 T3 ES 2190535T3 ES 97927282 T ES97927282 T ES 97927282T ES 97927282 T ES97927282 T ES 97927282T ES 2190535 T3 ES2190535 T3 ES 2190535T3
Authority
ES
Spain
Prior art keywords
compositions
manufacture
reduce
same
lectin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97927282T
Other languages
English (en)
Inventor
Arpad Janos Pusztai
Zsuszanna Magdolna Row Bardocz
Richard Michael John Al Palmer
Neil William Fish
Gyorgy J Frederic Joli Koteles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alizyme Therapeutics Ltd
Original Assignee
Alizyme Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795697&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2190535(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alizyme Therapeutics Ltd filed Critical Alizyme Therapeutics Ltd
Application granted granted Critical
Publication of ES2190535T3 publication Critical patent/ES2190535T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE AL USO DE LECTINAS EN LA FABRICACION DE MEDICAMENTOS QUE SIRVEN PARA LA LIMITACION DE LA PROLIFERACION DE LAS CELULAS MUCOSAS, PARA REDUCIR Y/O TRATAR LOS DAÑOS CAUSADOS POR LOS AGENTES QUE ATACAN LAS CELULAS Y REDUCIR Y/O TRATAR TRASTORNOS METABOLICOS. SE REFIERE ADEMAS A UNAS COMPOSICIONES Y REGIMENES QUE CONTIENEN LECTINAS, SU USO EN CAMPOS MEDICINALES Y NO MEDICINALES Y EL USO DE LOS DESECHOS DE SOJA, EN ESPECIAL DE LA PARTE LACTOSUERO, PARA LA FABRICACION DE LOS MEDICAMENTOS Y COMPOSICIONES MENCIONADOS ANTERIORMENTE.
ES97927282T 1996-06-21 1997-06-20 Composiciones de lectina y uso de las mismas. Expired - Lifetime ES2190535T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9613070.3A GB9613070D0 (en) 1996-06-21 1996-06-21 Dietary lectins

Publications (1)

Publication Number Publication Date
ES2190535T3 true ES2190535T3 (es) 2003-08-01

Family

ID=10795697

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97927282T Expired - Lifetime ES2190535T3 (es) 1996-06-21 1997-06-20 Composiciones de lectina y uso de las mismas.

Country Status (16)

Country Link
EP (1) EP0942741B1 (es)
JP (1) JP4379924B2 (es)
CN (1) CN1157225C (es)
AT (1) ATE229341T1 (es)
AU (1) AU738386B2 (es)
CA (1) CA2258503C (es)
DE (1) DE69717849T2 (es)
DK (1) DK0942741T3 (es)
ES (1) ES2190535T3 (es)
GB (1) GB9613070D0 (es)
NO (1) NO323880B1 (es)
NZ (1) NZ333411A (es)
PL (1) PL190301B1 (es)
PT (1) PT942741E (es)
RU (1) RU2202361C2 (es)
WO (1) WO1997049420A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132017A1 (en) 1996-12-09 2002-09-19 Moore Jeffrey G. Composition and method for preserving progenitor cells
US6310195B1 (en) 1997-06-24 2001-10-30 Imclone Systems Incorporated Nucleic acid encoding a lectin-derived progenitor cell preservation factor
US6991794B1 (en) 1997-06-24 2006-01-31 Imclone Systems Incorporated Progenitor cell preservation factors and methods for and products of their use
US20020169128A1 (en) * 2001-04-09 2002-11-14 Geroge Sigounas Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
KR100473422B1 (ko) * 2003-06-12 2005-03-14 박원봉 렉틴 함유 천연물의 장용성 코팅용 조성물
PL375746A1 (pl) * 2005-06-16 2006-12-27 Biolek Sp Z Oo Sposób otrzymywania preparatu lektynowego, preparat lektynowy oraz sposób podawania preparatu lektynowego dla ssaków
ATE539622T1 (de) 2008-04-02 2012-01-15 Helvista Ag Verwendung einer zusammensetzung, welche ein pflanzenlektin, ein proteolytisches enzym und eine selenverbindung umfasst, zum schleimhautschutz und zur linderung anderer symptome bei krebspatienten
ATE501724T1 (de) 2009-02-10 2011-04-15 Helvista Ag Lektinzusammensetzung zur prophylaxe und/oder behandlung von unerwünschten arzneimittelnebenwirkungen
DE102010033458B4 (de) * 2010-08-05 2016-03-10 Helvista Ag Emulgierte Lektinzusammensetzungen und ihre Verwendung
WO2012021076A2 (en) * 2010-08-12 2012-02-16 Biolek Sp. Z O.O. A method of extracting lectin from the common bean as well as a lectin preparation
ES2659763T3 (es) * 2011-02-14 2018-03-19 The Regents Of The University Of Michigan Composiciones y procedimientos para el tratamiento de obesidad y trastornos relacionados
EP2991647B1 (en) 2013-05-02 2019-04-24 The Regents Of The University Of Michigan Deuterated amlexanox with improved metabolic stability
EP3407974A4 (en) 2016-01-29 2019-08-28 The Regents Of The University Of Michigan Amlexanox Analogs
EP3243523B1 (de) 2016-05-11 2020-04-29 YACARE GmbH Lektine und krebsprophylaxe
US10918695B2 (en) 2019-01-03 2021-02-16 The Secretary, Department Of Atomic Energy Use of jack bean lectin for increasing the abundance of hematopoietic stem cells and progenitor cells in bone marrow and/or epidermal stem cells in skin in vivo
EP3701967B1 (en) 2019-02-26 2025-07-30 The Secretary, Department Of Atomic Energy Use of jack bean lectin for increasing the abundance of hematopoietic stem cells and progenitor cells in bone marrow and/or epidermal stem cells in skin in vivo
GB201903244D0 (en) 2019-03-14 2019-04-24 Syndermix Ag Methods for lectin production with improved yield
CN110433280A (zh) * 2019-09-11 2019-11-12 周口师范学院 植物血凝素在制备预防或治疗肥胖药物中的应用
CN112707958B (zh) * 2020-12-26 2023-08-29 郑州伊美诺生物技术有限公司 一种提取l型和e型植物凝集素的方法
EP4395806B1 (en) * 2021-08-30 2025-10-22 Unichem Laboratories Ltd Protein compositions for the treatment of oral mucositis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053386A (en) * 1987-07-24 1991-10-01 Tung Ta C Orally administrable anti-metastatic lectin compositions and methods
DE4318307A1 (de) * 1993-06-02 1994-12-08 Ludwig Dr Rer Nat Habil Jonas Einsatz von Lektinen zur Therapie der akuten und chronischen Pankreatitis des Menschen

Also Published As

Publication number Publication date
NO985980D0 (no) 1998-12-18
AU738386B2 (en) 2001-09-20
DE69717849T2 (de) 2003-11-13
DE69717849D1 (de) 2003-01-23
NZ333411A (en) 2000-08-25
AU3183297A (en) 1998-01-14
CA2258503C (en) 2009-08-11
ATE229341T1 (de) 2002-12-15
DK0942741T3 (da) 2003-04-07
GB9613070D0 (en) 1996-08-28
EP0942741B1 (en) 2002-12-11
CA2258503A1 (en) 1997-12-31
WO1997049420A1 (en) 1997-12-31
EP0942741A1 (en) 1999-09-22
CN1230891A (zh) 1999-10-06
PT942741E (pt) 2003-04-30
JP4379924B2 (ja) 2009-12-09
JP2001510447A (ja) 2001-07-31
PL190301B1 (pl) 2005-11-30
PL330865A1 (en) 1999-06-07
NO323880B1 (no) 2007-07-16
CN1157225C (zh) 2004-07-14
NO985980L (no) 1999-02-19
RU2202361C2 (ru) 2003-04-20

Similar Documents

Publication Publication Date Title
ES2190535T3 (es) Composiciones de lectina y uso de las mismas.
GT199900102A (es) Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen.
ES2144151T3 (es) Benzotiazepinas hipolipidemicas.
BR0211390A (pt) Tratamento de infecções da unha com no
CY1108659T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν ενα αμφοτερικο επιφανειοδραστικο, μια πολυπροποξυλιωμενη κετυλικη αλκοολη και μια πολικη φαρμακευτικη ουσια
BR0215405A (pt) Composições e processos de uso de collajolie
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
PT97065A (pt) Processo para a preparacao de 1,4,7,1o-tetraazaciclodecano-butiltrois e de composicoes farmaceuticas que os contem
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
BR0204115A (pt) Utilização de um copolìmero anfìfilo, processo de preparação de uma dispersão de um composto orgânico insolúvel, dispersão e composição cosmética de uso tópico
ES2082735T3 (es) Producto para el tratamiento del cabello y procedimiento para su utilizacion.
ES2170918T3 (es) Inhibidor de proteina quinasa c sustituidos con halo.
BR0213019B1 (pt) formulaÇço para uso na neutralizaÇço de pelo menos uma substÂncias tàxica.
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
ES2143666T3 (es) P-amidinobencilamidas dipeptidicas con restos sulfonilo, o bien aminosulfonilo n-terminales.
BR0210101A (pt) Combinações antineoplásticas
DK0563085T3 (da) Hidtil ukendte præparater
AR002017A1 (es) Derivados de fenil-4-tiazoles substituidos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y derivados defenil-4-tiazoles substituidos empleados en dicho procedimiento.
ES2092868T3 (es) Utilizacion de derivados de la 4-tiorresorcina en unas composiciones cosmeticas o dermofarmaceuticas de accion despigmentante.
BR9913718A (pt) Processo e composição farmacêutica ou veterinária para inibição profilática ou terapêutica de um material ou substância tóxica em um paciente animal humano ou não-humano, e, uso de um dendrìmero aniÈnico ou catiÈnico
ES2039267T3 (es) Dihidropiridinamidas, procedimiento para su preparacion y su empleo en medicamentos.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
ES2174297T3 (es) Nuevos derivados de piranosidos.